Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Accounts Payables: 2011-2023

Historic Accounts Payables for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2023 value amounting to $5.6 million.

  • SELLAS Life Sciences Group's Accounts Payables rose 4.77% to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.5 million, marking a year-over-year increase of 4.77%. This contributed to the annual value of $5.6 million for FY2023, which is 67.98% up from last year.
  • Latest data reveals that SELLAS Life Sciences Group reported Accounts Payables of $5.6 million as of FY2023, which was up 67.98% from $3.4 million recorded in FY2022.
  • In the past 5 years, SELLAS Life Sciences Group's Accounts Payables ranged from a high of $5.6 million in FY2023 and a low of $2.1 million during FY2021.
  • In the last 3 years, SELLAS Life Sciences Group's Accounts Payables had a median value of $3.4 million in 2022 and averaged $3.7 million.
  • In the last 5 years, SELLAS Life Sciences Group's Accounts Payables plummeted by 53.96% in 2021 and then soared by 67.98% in 2023.
  • SELLAS Life Sciences Group's Accounts Payables (Yearly) stood at $3.9 million in 2019, then rose by 19.35% to $4.7 million in 2020, then slumped by 53.96% to $2.1 million in 2021, then spiked by 56.58% to $3.4 million in 2022, then surged by 67.98% to $5.6 million in 2023.